These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 239155)
1. The interaction of aminoalkylaminoanthraquinones with deoxyribonucleic acid. Double JC; Brown JR J Pharm Pharmacol; 1975 Jul; 27(7):502-7. PubMed ID: 239155 [TBL] [Abstract][Full Text] [Related]
2. The molecular basis for the action of some DNA-binding drugs. Neidle S Prog Med Chem; 1979; 16():151-221. PubMed ID: 95595 [No Abstract] [Full Text] [Related]
3. SPECTROPHOTOMETRIC STUDIES OF THE INTERACTION OF CHLOROQUINE WITH DEOXYRIBONUCLEIC ACID. COHEN SN; YIELDING KL J Biol Chem; 1965 Jul; 240():3123-31. PubMed ID: 14342342 [No Abstract] [Full Text] [Related]
4. Ring-hydroxylated analogues of lucanthone as antitumor agents. Archer S; Miller KJ; Rej R; Periana C; Fricker L J Med Chem; 1982 Mar; 25(3):220-7. PubMed ID: 7069701 [TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of 2-substituted anthraquinones based on the anthracyclines. Bennett S; Sharples D; Brown JR J Med Chem; 1982 Apr; 25(4):369-73. PubMed ID: 7069715 [TBL] [Abstract][Full Text] [Related]
6. Extraction of daunorubicin and doxorubicin and their hydroxyl metabolites: self-association in aqueous solution. Eksborg S J Pharm Sci; 1978 Jun; 67(6):782-5. PubMed ID: 660455 [TBL] [Abstract][Full Text] [Related]
7. Experimental and computer graphics simulation analyses of the DNA interaction of 1,8-bis-(2-diethylaminoethylamino)-anthracene-9,10-dione, a compound modelled on doxorubicin. Islam SA; Neidle S; Gandecha BM; Brown JR Biochem Pharmacol; 1983 Sep; 32(18):2801-8. PubMed ID: 6626250 [TBL] [Abstract][Full Text] [Related]
8. The interaction of daunorubicin and doxorubicin with DNA and chromatin. Zunino F; Di Marco A; Zaccara A; Gambetta RA Biochim Biophys Acta; 1980 Apr; 607(2):206-14. PubMed ID: 7370266 [TBL] [Abstract][Full Text] [Related]
9. Effect of divalent cations on the daunomycin-deoxyribonucleic acid complex. Fishman MM; Schwartz I Biochem Pharmacol; 1974 Aug; 23(15):2147-54. PubMed ID: 4472085 [No Abstract] [Full Text] [Related]
10. Spectrophotometric and fluorescence polarization studies of the binding of ethidium, daunomycin and mepacrine to DNA and to poly(I-C). Plumbridge TW; Brown JR Biochim Biophys Acta; 1977 Dec; 479(4):441-9. PubMed ID: 922012 [TBL] [Abstract][Full Text] [Related]
11. Interaction of daunomycin and its derivatives with DNA. Zunino F; Gambetta R; Di Marco A; Zaccara A Biochim Biophys Acta; 1972 Sep; 277(3):489-98. PubMed ID: 4672222 [No Abstract] [Full Text] [Related]
12. Equilibrium and kinetic measurements of actinomycin binding to deoxyribonucleic acid in the presence of competing drugs. Blau L; Bittman R Mol Pharmacol; 1975 Nov; 11(6):716-21. PubMed ID: 128690 [No Abstract] [Full Text] [Related]
13. Interaction of indazole analogs of lucanthone and hycanthone with closed circular duplex deoxyribonucleic acid. Waring MJ J Pharmacol Exp Ther; 1973 Sep; 186(3):385-9. PubMed ID: 4728323 [No Abstract] [Full Text] [Related]
14. Nitro and amino derivatives of lucanthone as antitumor agents. Archer S; Rej R J Med Chem; 1982 Mar; 25(3):328-31. PubMed ID: 7069710 [TBL] [Abstract][Full Text] [Related]
15. Interaction of actinomycin D, ethidium, quinacrine, daunorubicin, and tetralysine with DNA: 31P NMR chemical shift and relaxation investigation. Wilson WD; Jones RL Nucleic Acids Res; 1982 Feb; 10(4):1399-410. PubMed ID: 7071016 [TBL] [Abstract][Full Text] [Related]
16. Thioxanthones. II. Studies on the hydrogen-bonding capacity of lucanthone. Zilversmit R Mol Pharmacol; 1971 Nov; 7(6):674-82. PubMed ID: 5148901 [No Abstract] [Full Text] [Related]
17. Interaction of some daunomycin derivatives with deoxyribonucleic acid and their biological activity. Di Marco A; Zunino F; Silverstrini R; Gambarucci C; Gambetta RA Biochem Pharmacol; 1971 Jun; 20(6):1323-8. PubMed ID: 5165732 [No Abstract] [Full Text] [Related]